Nicole Kidman latest celeb for supporting a hashish model

Article content

Nicole Kidman is the new face of SeraLabs, Inc., a subsidiary of CURE Pharmaceutical Holdings, announced the company today.

Kidman will be the brand’s first strategic partner and global ambassador for the company’s current products, which focus on antiaging, pain relief and moisturizing lines.

More on this subject

The company wanted to partner with someone who “cares about growing the business as much as we do,” said Nancy Duitch, CEO of SeraLabs.

“A person who just wanted to give their name would never work for us,” says Duitch. “[Kidman] is well-versed, future-oriented and embodies our brand values. “

The deal focuses on nine current current SeraLabs products and three other products that are expected to hit the market next year. According to the publication, Kidman will play a key role in its development.

“Partnering with SeraLabs was an easy decision for me,” says Kidman, 53, adding that she started experimenting with CBD after suffering an ankle injury last year.

“I believe these products are an important health and wellness solution, and Nancy and SeraLabs are a company I believe in,” said the Oscar winner.

SeraLabs was acquired by CURE Pharmaceutical Holdings earlier this year. It focuses on “innovation in pharmaceutical technology, wellness products and drug delivery,” according to the company.

“The growth and global interest in our latest acquisition, SeraLabs, has been tremendous over the past few months,” said Rob Davidson, CEO of CURE Pharmaceutical. “Nicole will undoubtedly help SeraLabs reach more consumers than ever before and grow our sales exponentially over the next few years,” added Davidson.

Comments are closed.